LumiThera Closes Series B Round of Financing

SEATTLE, Oct. 31, 2017 -- (Healthcare Sales & Marketing Network) -- LumiThera Inc., a clinical stage private medical device company creating a non-invasive photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has comple... Devices, Ophthalmology, Venture Capital, Personnel LumiThera, photobiomodulation, Age-related Macular Degeneration, dry AMD
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news